Tixagevimab

A4DAB270 | Approved
SARS-CoV-2 Spike RBD
G1 / None
AstraZeneca
Approved
Whole mAb
COV2-2196 COV2 2196 AZD-8895 AZD8895 AZD 8895 AZD7442 (combination of cilgavimab and tixagevimab) AZD-7442 (combination of cilgavimab and tixagevimab) EVUSHELD (combination of cilgavimab and tixagevimab)
—
Avg A4D Score
-0.7244
Score Range
-0.83 to -0.67
Structures
19
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB270_7l7d_H_L 7l7d 100% -0.7296 6.5 4.0 -0.3179 -0.7856
A4DAB270_7e3k_F_G 7e3k 95% -0.8068 6.5 4.0 -0.6704 -0.8248
A4DAB270_7mlz_H_L 7mlz 95% -0.7047 6.5 4.0 -0.3684 -0.7502
A4DAB270_8d8q_C_B 8d8q 100% -0.6892 7.0 4.0 -0.2495 -0.8169
A4DAB270_7u0d_O_P 7u0d 95% -0.6806 6.5 4.0 -0.3126 -0.7304
A4DAB270_8d8r_H_L 8d8r 100% -0.7015 7.0 4.0 -0.23 -0.8385
A4DAB270_7l7e_T_U 7l7e 99% -0.743 6.5 4.0 -0.3321 -0.7996
A4DAB270_7e3k_D_E 7e3k 95% -0.8282 6.5 4.0 -0.6631 -0.8501
A4DAB270_7tbf_H_L 7tbf 95% -0.6824 6.5 4.0 -0.333 -0.7296
A4DAB270_7tcc_O_P 7tcc 95% -0.6727 7.0 4.0 -0.3715 -0.7585
A4DAB270_7l7e_A_B 7l7e 99% -0.7302 6.5 4.0 -0.3108 -0.7874
A4DAB270_7tb8_H_L 7tb8 95% -0.6772 7.0 4.0 -0.3635 -0.767
A4DAB270_7b0b_H_L 7b0b 95% -0.7342 6.5 4.0 -0.1972 -0.8058
A4DAB270_7tcc_J_K 7tcc 95% -0.7177 7.0 4.0 -0.3792 -0.8141
A4DAB270_7l7e_I_J 7l7e 99% -0.7395 6.5 4.0 -0.3025 -0.7994
A4DAB270_7l7e_H_L 7l7e 99% -0.7264 6.5 4.0 -0.3319 -0.7804
A4DAB270_7e3k_H_L 7e3k 95% -0.8221 6.5 4.0 -0.6885 -0.8398
A4DAB270_7tcc_F_G 7tcc 95% -0.6923 6.5 4.0 -0.303 -0.8032
A4DAB270_7mm0_H_L 7mm0 95% -0.6849 7.0 4.0 -0.3907 -0.7692